The NHS England is launching a groundbreaking trial to facilitate same-day diagnoses of prostate cancer using artificial intelligence. This innovative program will assess 10,000 MRI scans across up to 15 hospitals nationwide and could be expanded throughout the country if proven effective.
The AI technology aims to analyze MRI scans for men suspected of having prostate cancer, enabling the detection of lesions within minutes. If the software identifies a scan as high-risk for cancer, it will be prioritized by a radiologist, allowing for same-day biopsy appointments.
Patients will receive results from specialists swiftly, with some potentially receiving an all-clear the same day while others may obtain a diagnosis within a few days. This advancement is expected to significantly reduce the lengthy waiting times currently experienced by men who undergo these tests.
Health Secretary Wes Streeting emphasized the urgency of this initiative, noting that prostate cancer affects thousands of men annually and that prolonged waits for test results can add unnecessary stress for patients and their families. He stated, “By harnessing the power of technology we are revolutionizing our NHS and tackling this, with AI able to deliver same-day prostate diagnoses, delivering better outcomes for patients and fast support for doctors.”
Professor Peter Johnson, the national clinical director for cancer at NHS England, expressed excitement about the potential of AI to expedite cancer diagnoses. He indicated that this trial could be transformative, alleviating weeks of anxiety for patients. “Speed is crucial – the quicker the diagnosis, the sooner treatment can begin,” he added.
Prostate cancer is the most prevalent cancer among men, with approximately one in eight men diagnosed in their lifetime, according to Prostate Cancer UK. Data from the National Prostate Cancer Audit reveals that over 58,000 men were diagnosed with prostate cancer in England in 2024, marking an increase from the previous year.
The new AI tool, named Pi, is developed by Lucida Medical and is being introduced ahead of the anticipated National Cancer Plan from the government, expected to be published later this year. According to Amy Rylance, assistant director of health improvement at Prostate Cancer UK, the implementation of AI could enhance the diagnostic process and result in fewer hospital visits for patients, while also alleviating the burden on NHS resources.
